-
Innovation Ranking
NewInnovation Ranking – Vedanta Ltd
Vedanta Ltd (Vedanta), formerly Sesa Sterlite Limited, is a diversified metal and mining company. The company, along with its subsidiaries, focuses on the exploration, mining, processing, and exporting of natural resources, power, and oil and gas businesses. Its product portfolio includes lead, zinc, silver, copper rod and cathodes, aluminum, iron ore, commercial power, steel, nickel and copper and oil and gas across India. It also carries out the production of pig iron and metallurgical coke. The company also provides support...
-
Product Insights
Veling Vedanta Iron Ore Mine
The Veling Vedanta Iron Ore Mine is a iron ore mine in India. It is currently in operation. Empower your strategies with our Veling Vedanta Iron Ore Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and...
-
Product Insights
Vedanta Jharsuguda Captive Power Plant
Vedanta Jharsuguda Captive Power Plant is a thermal project located in Odisha, India. The project is owned and developed by Vedanta Ltd. The project is partially active. Empower your strategies with our Vedanta Jharsuguda Captive Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may...
-
Company Insights
Innovation and Patenting activity of Vedanta Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Vedanta Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Sector Analysis
NewZinc Mining Market Analysis by Reserves, Production, Assets, Demand Drivers and Forecast to 2030
Zinc Mining Market Report Overview The zinc production increased for the third year in a row to 12.26 million tonnes (mt) in 2023 with China, Peru, Australia, India, and the US being the key contributors. Global zinc production was impacted by operational disruptions as well as low zinc prices in 2023. However, the zinc production output is expected to grow by 2.0% in 2024, but will relatively remain relatively flat in 2025, with a CAGR of less than 1% during...
-
Sector Analysis
Lead Mining Market Analysis by Reserves, Production, Assets, Demand Drivers and Forecast to 2030
Empower your strategies with our Global Lead Mining to 2026 report and make more profitable business decisions.Lead Mining Market Report Overview Lead production was estimated to be 4,522.1kt in 2023. The major factors that influenced global lead mine production in 2023 were lower production from Australia due to heavy rainfalls and planned lower grades mined from the largest mines. Furthermore, the placement of Ireland's Tara mine in care and maintenance, combined with lower grades mined at Sweden's Boliden Area Mines...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SGN-1 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SGN-1 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SGN-1 in Solid Tumor Drug Details: SGN-1 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VE-303 in Liver Cirrhosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VE-303 in Liver Cirrhosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VE-303 in Liver Cirrhosis Drug Details: VE-303 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VE-303 in Hepatic Encephalopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VE-303 in Hepatic Encephalopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VE-303 in Hepatic Encephalopathy Drug Details: VE-303 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VE-303 in Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VE-303 in Clostridioides difficile Infections (Clostridium difficile Associated Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VE-303 in Clostridioides difficile Infections (Clostridium difficile...